For example, Frank Cichocki and others demonstrated that in the existence of GSK3 inhibitor CHIR99021, the production of tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) by NK cells was significantly increased, which enhanced NK cytotoxicity, fueled immunotherapy of cancer [97]. The gene discussed is TNF; the disease is cancer.